Study guide

13.1 Acute Gastroenteritis, Dehydration Assessment & WHO ORS Protocols

CAMC Regional Medical Registration Examination Part 1 MCQ

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview, Registration Framework & Test Strategy

1.1 Exam Format, Administration & Caribbean Medical Registration Pathways 1.2 Clinical Reasoning & Single-Best-Answer MCQ Test-Taking Strategy 1.3 Regional Epidemiology & Caribbean Healthcare Context

2 Chapter 2: Internal Medicine: Cardiovascular Disorders

2.1 Acute Coronary Syndromes & Myocardial Infarction Management 2.2 Heart Failure Syndromes & Cardiogenic Shock 2.3 Cardiac Arrhythmias, Conduction Blocks & BLS/ACLS Algorithms 2.4 Valvular Heart Disease, Infective Endocarditis & Hypertension

3 Chapter 3: Internal Medicine: Respiratory Medicine & Critical Care

3.1 Asthma & Chronic Obstructive Pulmonary Disease Exacerbations 3.2 Community-Acquired Pneumonia, Hospital-Acquired Pneumonia & Tuberculosis 3.3 Pulmonary Embolism, Pleural Effusion & Pneumothorax

4 Chapter 4: Internal Medicine: Endocrinology & Metabolic Disorders

4.1 Diabetes Mellitus, Diabetic Ketoacidosis & Hyperosmolar Hyperglycaemic State 4.2 Thyroid Disorders: Thyrotoxicosis, Hypothyroidism & Thyroid Storm 4.3 Adrenal Disorders, Pituitary Pathology & Calcium Homeostasis

5 Chapter 5: Internal Medicine: Gastroenterology, Hepatology & Nephrology

5.1 Upper & Lower Gastrointestinal Bleeding: Evaluation & Management 5.2 Cirrhosis, Portal Hypertension & Hepatic Encephalopathy 5.3 Acute Kidney Injury & Chronic Kidney Disease Staging 5.4 Fluid, Electrolyte & Acid-Base Emergencies

6 Chapter 6: Internal Medicine: Neurology, Haematology & Infectious Diseases

6.1 Stroke, Transient Ischaemic Attack & Acute Neurological Deficits 6.2 Sickle Cell Disease, Haemoglobinopathies & Transfusion Medicine 6.3 Dengue Fever, Arboviral Infections & Leptospirosis 6.4 HIV/AIDS, Opportunistic Infections & Antimicrobial Stewardship

7 Chapter 7: General Surgery: Acute Abdomen & Surgical Emergencies

7.1 Acute Abdomen: Peritonitis, Appendicitis & Acute Cholecystitis 7.2 Intestinal Obstruction, Bowel Ischaemia & Perforated Viscus 7.3 Abdominal Wall Hernias: Inguinal, Femoral, Umbilical & Strangulation 7.4 Upper & Lower GI Surgical Pathology & Postoperative Complications

8 Chapter 8: General Surgery: Trauma Resuscitation, Shock & Critical Care

8.1 ATLS Primary Survey & Hemorrhagic Shock Resuscitation 8.2 Thoracic Trauma: Tension Pneumothorax, Hemothorax & Flail Chest 8.3 Abdominal & Pelvic Trauma: FAST Examination & Damage Control Surgery 8.4 Traumatic Brain Injury, Burns & Wound Management

9 Chapter 9: General Surgery: Surgical Subspecialties & Perioperative Care

9.1 Urological Emergencies: Acute Retention, Renal Colic, Torsion & Hematuria 9.2 Musculoskeletal Trauma: Fractures, Dislocations & Compartment Syndrome 9.3 Preoperative Assessment, Surgical Site Infections & Fluid Management 9.4 Otolaryngology: Ear, Nose, Throat & Upper Airway Emergencies 9.5 Clinical Ophthalmology: Acute Red Eye, Glaucoma & Retinal Emergencies

10 Chapter 10: Obstetrics: Antenatal Care, Labor & Complications

10.1 Routine Antenatal Care, Screening & Fetal Assessment 10.2 Hypertensive Disorders of Pregnancy: Pre-eclampsia & Eclampsia 10.3 Antepartum Haemorrhage: Placenta Praevia & Placental Abruption 10.4 Normal Labor, Labor Dystocia & Obstetric Analgesia

11 Chapter 11: Obstetrics & Gynaecology: Postpartum & Pathology

11.1 Postpartum Haemorrhage, Normal Puerperium Physiology & Postpartum Care 11.2 Ectopic Pregnancy, Miscarriage & Gestational Trophoblastic Disease 11.3 Abnormal Uterine Bleeding & Pelvic Inflammatory Disease 11.4 Contraception, Cervical Cancer Screening & Gynaecological Malignancies 11.5 Obstetric & Gynaecological Instruments & Cervical Specimen Collection (PAP Smear Procedures)

12 Chapter 12: Paediatric Medicine: Neonatal Care, Growth & Nutrition

12.1 Neonatal Resuscitation, APGAR Scoring & Prematurity Complications 12.2 Neonatal Jaundice: Physiological, Pathological & Kernicterus 12.3 Growth Monitoring, Developmental Milestones & Failure to Thrive 12.4 Protein-Energy Malnutrition: Kwashiorkor, Marasmus & Nutritional Deficiencies

13 Chapter 13: Paediatric Medicine: Common Illnesses & Emergencies

13.1 Acute Gastroenteritis, Dehydration Assessment & WHO ORS Protocols 13.2 Paediatric Respiratory Illness: Croup, Bronchiolitis & Asthma 13.3 Childhood Infections, Exanthems & Caribbean Immunisation Schedules 13.4 Paediatric Surgical & Medical Emergencies: Intussusception & Febrile Seizures 13.5 Social Paediatrics, Child Protection & Vulnerable Child Health

14 Chapter 14: Psychiatry: Clinical Assessment & Psychopharmacology

14.1 Depressive Disorders, Bipolar Affective Disorder & Suicide Risk Assessment 14.2 Psychosis, Schizophrenia & Acute Delirium vs Dementia 14.3 Anxiety Disorders, Substance Misuse & Psychotropic Side Effects

15 Chapter 15: Community Health, Epidemiology & Preventive Medicine

15.1 Epidemiological Study Designs, Measures of Association & Bias 15.2 Screening Test Performance: Sensitivity, Specificity, PPV & NPV 15.3 Outbreak Investigation, Levels of Prevention & Caribbean NCD Control

16 Chapter 16: Internal Medicine: Rheumatology, Connective Tissue & Dermatology

16.1 Connective Tissue & Collagen Vascular Diseases 16.2 Bone & Joint Diseases: Non-Traumatic Arthropathies & Metabolic Bone Disorders 16.3 Clinical Dermatology: Common, Inflammatory, Bullous, Malignant & Drug-Induced Dermatoses

17 Chapter 17: Anaesthetics, Intensive Care & Clinical Measurements

17.1 Important Anaesthetic Techniques, Airway Management & Methods of Administration 17.2 Clinical Measurements & Intensive Care Monitoring: Cardiac Output, Arterial Blood Gases & Pulmonary Functions 17.3 Acute Pain Management, Multimodal Analgesia & Critical Care Sedation

13.1 Acute Gastroenteritis, Dehydration Assessment & WHO ORS Protocols

Key Takeaways Explain This Topic AI

Acute gastroenteritis in children is predominantly viral (Rotavirus, Norovirus), but bacterial pathogens (Campylobacter, Salmonella, Shigella) cause invasive dysentery; anti-motility agents like loperamide are strictly contraindicated in paediatric diarrhea due to risks of toxic megacolon, paralytic ileus, and central neurotoxicity.

The World Health Organization (WHO) classifies dehydration into three clinical tiers: No Dehydration (Plan A: home fluids, continued feeding/breastfeeding, and oral zinc: WHO2024 suggests 5 mg/day for 10–14 days in children up to 10 years), Some/Moderate Dehydration (Plan B: reduced-osmolarity ORS 75 mL/kg over 4 hours), and Severe Dehydration (Plan C: emergency IV Ringer's lactate or normal saline 100 mL/kg total).

Under WHO Plan C intravenous resuscitation, infants (< 12 months) receive 30 mL/kg over 1 hour followed by 70 mL/kg over 5 hours (total 6 hours), whereas older children (>= 12 months) receive 30 mL/kg over 30 minutes followed by 70 mL/kg over 2.5 hours (total 3 hours), initiating oral ORS as soon as the child can swallow safely.

WHO reduced-osmolarity ORS (total osmolarity 245 mOsm/L: glucose 75 mmol/L, sodium 75 mmol/L, chloride 65 mmol/L, potassium 20 mmol/L, citrate 10 mmol/L) leverages the intact mucosal SGLT1 sodium-glucose cotransporter (2 sodium ions per glucose molecule) to drive passive paracellular fluid absorption, reducing stool output by 20% and unscheduled IV fluid requirement by 33% compared to older hyperosmolar solutions.

Most childhood gastroenteritis needs supportive care. Antimicrobials are reserved for selected infections: bacterial dysentery, cholera with severe illness/high output or risk factors, symptomatic protozoal disease, invasive salmonellosis or other systemic infection. Select treatment by pathogen and local susceptibility; avoid antibiotics in suspected STEC.

Last updated: November 2026

Etiology & Pathophysiology of Acute Diarrhea in Children

Acute gastroenteritis remains one of the leading causes of morbidity and mortality in infants and young children across the Caribbean and globally. Diarrhea is clinically defined as the passage of three or more loose or watery stools within a 24-hour period (or a frequency noticeably greater than normal for the child). Acute diarrhea lasts fewer than 14 days; persistent diarrhea extends between 14 and 29 days; and chronic diarrhea persists for 30 days or longer.

Infectious Etiologies in the Caribbean

Viral Pathogens (70% to 80% of Cases) :

Rotavirus : A double-stranded RNA reovirus historically responsible for the majority of severe, dehydrating infantile diarrhea. It infects and destroys mature, absorptive enterocytes lining the tips of the small intestinal villi, sparing immature crypt cells. The viral non-structural protein 4 (NSP4) acts as an enterotoxin, triggering intracellular calcium release and active chloride secretion. Routine vaccination with pentavalent (RV5) or monovalent (RV1) live-attenuated oral vaccines has dramatically reduced hospitalization rates across Caribbean territories.

Norovirus : A positive-sense single-stranded RNA calicivirus, now the leading cause of epidemic and sporadic acute gastroenteritis in vaccinated populations. Characterized by prominent, explosive non-bilious projectile vomiting, watery non-bloody diarrhea, low-grade fever, and crampy abdominal pain following a brief 12-to-48-hour incubation period. Highly contagious via low infectious inocula and environmental stability.

Enteric Adenovirus (Serotypes 40/41) & Astrovirus : Cause mild to moderate watery diarrhea and protracted illness lasting 7 to 10 days in young children.

Bacterial Pathogens (15% to 20% of Cases) :

Campylobacter jejuni : Acquired through contaminated poultry, unpasteurized milk, or untreated water. Causes acute inflammatory diarrhea with high fever, severe periumbilical abdominal pain (frequently mimicking acute appendicitis), and stools containing blood and leukocytes. Associated with post-infectious Guillain-Barré syndrome and reactive arthritis.

Salmonella enterica (Non-typhoidal) : Acquired via undercooked poultry, eggs, or contact with reptilian pets (turtles, iguanas). Produces enterocolitis with nausea, vomiting, fever, and green watery or mucoid stools. In infants under 3 months, immunocompromised children, or patients with sickle cell disease (HbSS) —prevalent across the Caribbean—Salmonella bacteremia can seed bones and joints, causing acute osteomyelitis or septic arthritis.

Shigella species (S. sonnei, S. flexneri, S. dysenteriae) : Highly virulent organism with an infectious dose as low as 10 to 100 bacilli. Invades colonic enterocytes, causing mucosal microabscesses, intense mucosal inflammation, superficial ulceration, high fever, tenesmus, and the classic clinical syndrome of dysentery (frequent, small-volume stools composed almost entirely of gross blood, mucus, and pus). S. dysenteriae type 1 produces Shiga toxin, precipitating hemolytic uremic syndrome (HUS).

Escherichia coli Variants :

Enterotoxigenic E. coli (ETEC) : Major cause of traveler's diarrhea and infantile watery diarrhea in developing regions. Produces heat-labile (LT) and heat-stable (ST) enterotoxins that stimulate adenylate and guanylate cyclase, respectively, provoking massive, painless, watery secretory diarrhea.

Enterohemorrhagic E. coli (EHEC / Shiga toxin-producing E. coli [STEC], e.g., O157:H7) : Transmitted via undercooked ground beef or contaminated produce. Causes afebrile or low-grade febrile bloody diarrhea. Antibiotic administration is strictly contraindicated as it stimulates bacterial stress responses and phage lysis, increasing Shiga toxin release and dramatically elevating the risk of Hemolytic Uremic Syndrome (HUS) (triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury).

Parasitic Pathogens (5% of Cases) :

Giardia lamblia (duodenalis) : Flagellated protozoan acquired by ingesting cysts from contaminated water sources or daycare centers. Trophozoites adhere to duodenal and jejunal brush border enterocytes, flattening microvilli without tissue invasion. Causes malabsorptive, foul-smelling, pale, greasy, frothy stools, bloating, flatulence, anorexia, and weight loss.

Entamoeba histolytica : Causes amebic dysentery with colonic flask-shaped ulcers, trophozoites containing ingested red blood cells, and potential extraintestinal amebic liver abscesses.

Cryptosporidium parvum : Intracellular protozoan causing self-limiting watery diarrhea in immunocompetent children, but prolonged, life-threatening choleriform diarrhea in immunocompromised children (e.g., advanced pediatric HIV).

Pathophysiological Classification: Secretory, Osmotic & Invasive

Diarrheal Mechanism Pathophysiological Process Stool Characteristics Effect of Fasting Common Pathogens

Secretory Active net secretion of chloride and bicarbonate ions into the lumen, or inhibition of electroneutral sodium absorption, mediated by elevated intracellular cAMP, cGMP, or calcium Copious, watery, large-volume, isotonic; stool osmotic gap < 50 mOsm/kg Diarrhea persists unabated despite fasting Vibrio cholerae, ETEC, Rotavirus (NSP4 enterotoxin)

Osmotic Ingestion or malabsorption of poorly absorbable, osmotically active luminal solutes, drawing fluid passively across mucosal gradients Watery, acidic (pH < 5.5), positive for reducing substances; stool osmotic gap > 100 mOsm/kg Diarrhea ceases or diminishes markedly with fasting Rotavirus (lactase deficiency), Giardia, lactose intolerance

Invasive / Inflammatory Direct mucosal penetration, cellular destruction, cytokine release, neutrophil recruitment, and mucosal ulceration Frequent, small-volume stools with gross blood, mucus, and fecal leukocytes; associated with high fever and tenesmus Diarrhea persists ; accompanied by systemic signs Shigella, Campylobacter, Salmonella, EIEC, E. histolytica

WHO Clinical Dehydration Assessment & Classification

The World Health Organization (WHO) framework classifies dehydration into three categories based on clinical signs that reflect intravascular and interstitial volume depletion. Laboratory measurements (electrolytes, urea, creatinine, blood gas) are not required for initiating treatment and should never delay prompt clinical rehydration.

Clinical Assessment Matrix

Assessment Parameter No Dehydration (< 5% Fluid Deficit) Some / Moderate Dehydration (5% to 10% Fluid Deficit) Severe Dehydration (> 10% Fluid Deficit)

Sensorium & Mental State Well, alert, interactive Restless, irritable, agitated Lethargic, obtunded, unconscious, floppy

  • Eyes Normal, not sunken Sunken Deeply sunken, dry
  • Tears Present when crying Absent or markedly decreased Absent
  • Mouth & Tongue Wet, moist mucous membranes Dry Very dry, parched, cracked

Thirst / Drinking Ability Drinks normally; not thirsty Thirsty; drinks eagerly and voraciously Drinks poorly or unable to drink/swallow

Skin Pinch (Skin Turgor) Goes back immediately (< 1 second) Goes back slowly (retracts in 1 to 2 seconds) Goes back very slowly (> 2 seconds; tenting)

Radial Pulses Strong, full volume Normal to slightly rapid, palpable Weak, thready, or impalpable

Capillary Refill Time Normal (< 2 seconds) Prolonged (2 to 3 seconds) Markedly prolonged (> 3 seconds; cold peripheries)

Diagnostic Classification Child has NO signs sufficient to classify as Some or Severe Child has TWO OR MORE of: Restless/irritable, Sunken eyes, Drinks eagerly/thirsty, Skin pinch goes back slowly Child has TWO OR MORE of: Lethargic/unconscious, Sunken eyes, Unable to drink/drinks poorly, Skin pinch goes back very slowly

Treatment Protocol WHO Plan A (Home fluid therapy & feeding) WHO Plan B (Oral rehydration therapy in clinic) WHO Plan C (Emergency intravenous fluid resuscitation)

WHO Evidence-Based Rehydration Protocols: Plans A, B & C +-----------------------------------------------------------------------------------------+

  • | WHO THREE-TIER REHYDRATION MANAGEMENT MATRIX |
  • +-----------------------------------------------------------------------------------------+
  • | PLAN A: NO DEHYDRATION (Home Care) |
  • | - Give extra fluids: ORS, clean water, soup, continued frequent breastfeeding |
  • | - Oral Zinc: WHO2024 suggests 5 mg/day x 10-14 days in children up to 10 years |
  • | - Continue age-appropriate feeding; never dilute milk; review danger signs |
  • +-----------------------------------------------------------------------------------------+
  • | PLAN B: SOME DEHYDRATION (Supervised Clinic Care) |
  • | - WHO Reduced-Osmolarity ORS: 75 mL/kg administered orally over 4 hours |
  • | - If child vomits, pause 10 minutes, then resume at slower rate (1 spoon every 2-3 min) |
  • | - Reassess clinical hydration status at 4 hours -> Select Plan A, Plan B, or Plan C |
  • +-----------------------------------------------------------------------------------------+
  • | PLAN C: SEVERE DEHYDRATION (Emergency Inpatient Resuscitation) |
  • | - IV Ringer's Lactate (or 0.9% Normal Saline) total 100 mL/kg: |
  • | * Infants (< 12 months): 30 mL/kg in 1 hour -> then 70 mL/kg in 5 hours (total 6 h) |
  • | * Older Children (>= 12 months): 30 mL/kg in 30 min -> then 70 mL/kg in 2.5 h (total 3 h)|
  • | - Give oral ORS (5 mL/kg/h) as soon as child can swallow; reassess every 15-30 minutes |
  • +-----------------------------------------------------------------------------------------+
  • Plan A: Home Management & Prevention of Dehydration

Indicated for children with acute diarrhea who exhibit no signs of dehydration. Managed at home by parents following four essential rules:

Provide Extra Fluids : Offer more fluids than usual to replace ongoing losses. After each loose stool, administer: 50 to 100 mL of fluid for children under 2 years of age; 100 to 200 mL of fluid for children 2 years of age and older. Acceptable fluids include WHO ORS solution, clean drinking water, salted rice water, vegetable soups, and continuous breast milk. Avoid commercial fruit juices, sweetened sodas, and sports drinks because their high sucrose/fructose concentration and high osmolarity (> 350-500 mOsm/L) exacerbate osmotic diarrhea.

Zinc Supplementation : WHO2024 suggests 5 mg elemental zinc once daily for 10 to 14 days in children up to 10 years with acute watery or persistent diarrhea. This conditional recommendation replaces the previous 10/20 mg age-based dosing.

Mechanism : Zinc acts as a potassium channel blocker, stimulates mucosal brush border enzyme synthesis (alkaline phosphatase, disaccharidases), enhances enterocyte regeneration, tightens intercellular junctions, and strengthens cell-mediated immunity. Clinical trials demonstrate zinc reduces diarrhea duration by 25% and cuts subsequent diarrhea episodes over the following 3 months by 30%.

Continue Feeding : Never withhold food or dilute formula. Continued enteral nutrition preserves mucosal villous architecture, prevents nutrient malabsorption, and accelerates gut recovery. Provide small, frequent, nutrient-dense meals (cereals, bananas, lean meat, yogurt).

Counsel on Danger Signs : Educate caregivers to return immediately to the healthcare facility if the child develops: intractable vomiting (unable to retain any oral intake), increasing lethargy or floppiness, deeply sunken eyes, extreme thirst, fever, or stools containing blood.

Plan B: Oral Rehydration Therapy for Some Dehydration

Indicated for children classified with some/moderate dehydration. Managed under direct clinical observation in a primary healthcare facility or oral rehydration unit over a 4-hour period :

Dosing : Administer 75 mL/kg of WHO reduced-osmolarity ORS solution over 4 hours (or follow the WHO weight-independent age chart: < 4 months [200-400 mL]; 4-11 months [400-700 mL]; 12-23 months [700-900 mL]; 2-5 years [900-1400 mL]).

Administration Technique : Teach the caregiver to give ORS using a clean cup or spoon. For infants, deliver 1 teaspoon (5 mL) every 1 to 2 minutes. Frequent small sips are better tolerated than large volumes.

Management of Emesis : Vomiting is common during early gastroenteritis. If the child vomits, wait 10 minutes to allow gastric irritability to subside, then resume ORS administration at a slightly slower pace (e.g., 1 spoonful every 2 to 3 minutes).

Breastfeeding : Breastfed infants must continue on-demand breastfeeding throughout the 4-hour rehydration period between sips of ORS.

Reassessment at 4 Hours :

If dehydration has completely resolved: Transition to Plan A ; discharge home with ORS packets, zinc, and caregiver education.

If signs of some dehydration persist: Repeat Plan B for another 4 hours, introducing small amounts of food/breast milk.

If the child has deteriorated into severe dehydration: Transition immediately to Plan C .

Plan C: Emergency Intravenous Resuscitation for Severe Dehydration

Severe dehydration is a medical emergency and can progress to hypovolemic shock; assess perfusion separately. Standard Plan C below is for children without SAM; SAM requires its specific monitored fluid regimen. Immediate intravenous access must be secured; if peripheral cannulation fails within 5 minutes, an intraosseous (IO) needle must be placed into the proximal tibia without delay.

Fluid Selection : Ringer's Lactate (Hartmann's Solution) is the preferred resuscitation crystalloid because its electrolyte profile closely mimics extracellular fluid and its lactate buffer is metabolized by the liver into bicarbonate, directly correcting metabolic acidosis. If Ringer's Lactate is unavailable, Isotonic 0.9% Normal Saline is an acceptable alternative. Hypotonic solutions (e.g., 5% Dextrose in water, 0.18% or 0.45% saline) are strictly contraindicated for acute volume resuscitation as they produce rapid cerebral edema and fatal hyponatremia.

Total Volume : 100 mL/kg administered according to the strict WHO age-stratified timeline:

  • Patient Age Initial Rapid Bolus Phase Slower Replacement Phase Total Rehydration Time
  • Infants (< 12 months) 30 mL/kg over 1 hour (60 minutes) 70 mL/kg over 5 hours (300 minutes) 6 Hours total
  • Older Children (>= 12 months) 30 mL/kg over 30 minutes 70 mL/kg over 2.5 hours (150 minutes) 3 Hours total

Monitoring & Transition to Oral Intake :

Reassess the child every 15 to 30 minutes. If the radial pulse remains very weak or absent after the initial 30 mL/kg, repeat that volume over the same duration with reassessment before the 70 mL/kg phase. Persistent shock requires urgent senior review of the cause and fluid response.

As soon as the child regains full consciousness and can swallow safely (usually after 3 to 4 hours in infants, or after 1 to 2 hours in older children), initiate oral ORS at a rate of 5 mL/kg/hour while the IV infusion continues. Oral intake provides essential potassium and base precursors, stimulating intestinal enterocyte recovery.

Upon completion of the full IV regimen (6 hours for infants, 3 hours for older children), fully reassess the child to select Plan A, Plan B, or repeat Plan C.

Biophysical Mechanism & Formulation of WHO Reduced-Osmolarity ORS

Oral Rehydration Therapy (ORT) is hailed as one of the greatest medical breakthroughs of the twentieth century, drastically reducing global under-5 diarrheal mortality. Its success rests upon an elegant cellular physiological mechanism that remains intact despite severe enterotoxin-mediated secretory diarrhea.

The SGLT1 Cotransport Mechanism

The apical brush border membrane of mature small intestinal enterocytes possesses a specialized transport protein: the Sodium-Glucose Cotransporter 1 (SGLT1) . SGLT1 couples the transport of two sodium ions (Na+) to one glucose molecule down the electrochemical gradient for sodium into the enterocyte cytoplasm. This gradient is continuously maintained by the basolateral ATP-dependent Na+/K+ ATPase pump , which extrudes sodium into the paracellular space while pumping potassium into the cell.

In cholera and other toxin-mediated secretory diarrheas, bacterial toxins activate adenylate cyclase or guanylate cyclase, elevating intracellular cAMP or cGMP, which opens the CFTR chloride channel and inhibits electroneutral Na+/H+ exchangers. Crucially, the SGLT1 cotransport pathway is completely independent of cyclic nucleotides and remains 100% functional . Sodium and glucose supplied by ORS are absorbed through SGLT1; the solution's equimolar concentrations do not imply a 1:1 transporter stoichiometry. The accumulation of sodium and glucose in the intercellular space creates a powerful osmotic gradient that draws water passively from the gut lumen through paracellular tight junctions and transcellular aquaporin channels back into the systemic circulation.

Formulation Comparison: Reduced-Osmolarity vs Original ORS

In 2002, the WHO and UNICEF revised the standard ORS formula, transitioning from the older citrate-based formulation (311 mOsm/L) to the current reduced-osmolarity ORS (245 mOsm/L) .

Component Older Citrate-Based WHO ORS Current Reduced-Osmolarity ORS (2002-Present) Clinical Physiological Rationale

Total Osmolarity 311 mOsm/L 245 mOsm/L Reduced osmolarity avoids hypertonic luminal fluid shifts, preventing osmotic diarrhea

Glucose 111 mmol/L (20.0 g/L) 75 mmol/L (13.5 g/L) Supports sodium-glucose absorption with a lower luminal osmotic load; solution ratio is not transporter stoichiometry

  • Sodium 90 mmol/L 75 mmol/L Sufficient to replace losses while avoiding hypernatremia in rotavirus diarrhea
  • Chloride 80 mmol/L 65 mmol/L Balances sodium and potassium cations
  • Potassium 20 mmol/L 20 mmol/L Replaces heavy stool potassium losses, preventing hypokalemic paralytic ileus

Citrate (Trisodium citrate) 10 mmol/L (2.9 g/L) 10 mmol/L (2.9 g/L) Corrects metabolic acidosis and enhances shelf-life stability in tropical climates

Evidence-Based Clinical Benefits : Systematic Cochrane reviews confirmed that reduced-osmolarity ORS (245 mOsm/L) produces a 20% to 25% reduction in stool output , a 30% reduction in vomiting episodes , and a 33% reduction in the requirement for unscheduled intravenous fluid infusions compared to the original 311 mOsm/L formulation.

  • Antimicrobial Stewardship & Pharmacological Contraindications
  • Strict Indications for Antimicrobial Therapy

Antimicrobial therapy is NOT indicated for the vast majority of children with acute gastroenteritis. Indiscriminate antibiotic prescribing accelerates global antimicrobial resistance, disrupts protective indigenous gut microflora, prolongs Salmonella carrier states, and carries toxic side effects.

Treat selected enteric or systemic infections according to the likely pathogen and local susceptibility. Important indications include:

Invasive Bacterial Dysentery : High fever, systemic toxicity, tenesmus, and frequent small stools containing gross blood and mucus (suspected Shigella, severe Campylobacter, or EIEC).

First-line : Oral Azithromycin (10 to 12 mg/kg on day 1, followed by 5 mg/kg once daily for 4 days) OR oral Ciprofloxacin (15 mg/kg twice daily for 3 days; benefit outweighs theoretical cartilage toxicity risks in severe dysentery).

Second-line : Intravenous Ceftriaxone (50 to 100 mg/kg once daily for 3 to 5 days) for children unable to tolerate oral intake or in toxic septic shock.

Cholera with Severe Dehydration, High Purging, Rehydration Failure or High-Risk Comorbidity :

First-line : Single-dose oral Azithromycin (20 mg/kg, max 1.0 g) or Doxycycline (2 to 4 mg/kg single dose in children >= 8 years). Reduces duration of diarrhea and fluid requirements.

Treatable Protozoal Infection :

Persistent diarrhea (> 14 days) with malabsorptive stools and confirmed cysts/trophozoites on microscopy or stool antigen ELISA.

Giardiasis Therapy : Oral Metronidazole (15 mg/kg/day divided three times daily for 5–7 days) or Tinidazole (50 mg/kg single dose, max 2 g).

Confirmed Amoebic Colitis : Give tissue-active metronidazole or tinidazole, followed by a luminal agent such as paromomycin; treatment must eradicate both invasive disease and intestinal carriage.

High-Risk Salmonella Enteritis :

While immunocompetent older children with non-typhoidal Salmonella enterocolitis require supportive care only, antibiotics (IV Ceftriaxone or oral Ciprofloxacin) are mandatory for: infants < 3 months of age, children with Sickle Cell Disease (to prevent Salmonella bacteremia and osteomyelitis), severe malnutrition, or systemic bacteremia.

Absolute Contraindications: Antimotility Agents & Antidiarrheals

In Caribbean registration examinations, questions regarding antidiarrheal pharmacotherapy are high-frequency safety checkpoints:

Antimotility Agents (Loperamide, Diphenoxylate-Atropine) : STRICTLY CONTRAINDICATED in all children presenting with acute diarrhea. By paralyzing intestinal smooth muscle, these agents inhibit physiological peristaltic clearance of pathogens and toxins, inducing bacterial translocation, systemic septicemia, toxic megacolon , intestinal perforation, severe paralytic ileus, and fatal central nervous system depression.

Bismuth Subsalicylate : Contraindicated in children due to mucosal absorption of salicylate and the risk of Reye syndrome (acute encephalopathy with fatty hepatic microvesicular degeneration), particularly during viral influenza or varicella co-infections.

Adsorbents (Kaolin-pectin, activated charcoal) : Ineffective; they may alter stool consistency without reducing actual fluid and electrolyte losses, and they bind essential nutrients, vitamins, and oral medications.

Role of Antiemetics

Routine antiemetic administration is generally discouraged in primary pediatric diarrhea. However, in emergency department settings where persistent non-bilious vomiting prevents successful oral rehydration under Plan B, a single dose of oral ondansetron (0.15 mg/kg, max 8 mg) may be used in children >=6 months after assessment. Avoid it with ileus or congenital long-QT syndrome; assess electrolyte abnormalities and other QT-prolonging risks. Ondansetron (a 5-HT3 receptor antagonist) significantly decreases vomiting, improves the success rate of oral rehydration therapy, and reduces hospital admission rates. Conversely, phenothiazines (promethazine) and dopamine antagonists (metoclopramide) are strictly contraindicated due to severe risks of sedating obtundation, respiratory depression, and acute extrapyramidal dystonic reactions.

Loading diagram... WHO Paediatric Dehydration Assessment & Clinical Rehydration Protocols (Plans A, B & C)